The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
CB 1 and CB 2 Receptor Pharmacology
Open accessAbstract
The CB1 and CB2 cannabinoid receptors (CB1R, CB2R) are members of the G protein coupled receptor (GPCR) family that were identified over 20 years ago. CB1Rs and CB2Rs mediate the effects of Δ9-tetrahydrocannabinol (Δ9-THC), the principal psychoactive constituent of marijuana and subsequently identified endogenous cannabinoids (endocannabinoids) anandamide and 2-arachidonoyl glycerol. CB1Rs and CB2Rs have both similarities and differences in their pharmacology. Both receptors recognize multiple classes of agonist and antagonist compounds and produce an array of distinct downstream effects. Natural polymorphisms and alternative splice variants may also contribute to their pharmacological diversity. As our knowledge of the distinct differences grows, we may be able to target select receptor conformations and their corresponding pharmacological responses. This chapter will discuss their pharmacological characterization, distribution, phylogeny and signaling pathways. In addition, the effects of extended agonist exposure and how that affects signaling and expression patterns of the receptors is considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationCellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Dos Santos, S. E., Porfirio, J., da Cunha, F. B., Manger, P. R., Tavares, W., Pessoa, L., Raghanti, M. A., Sherwood, C. C., & Herculano-Houzel, S. (2017) · Brain, Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,642
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationCannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 2×
“The CB1 receptor is one of the most abundant GPCRs in the brain; it is highly expressed in the basal ganglia nuclei, hippocampus, cortex and cerebellum (Glass, Dragunow, & Faull, 1997; Herkenham et al., 1990) (Tsou, Brown, Sanudo-Pena, Mackie, & Walker, 1998) (reviewed in (Howlett et al.”
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Self-citationImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Molecular phylogenetics and the origins of placental mammals
Murphy, W. J., Eizirik, E., Johnson, W. E., Zhang, Y. P., Ryder, O. A., & O'Brien, S. J. (2001) · Nature · doi:10.1038/35054550 · Cited by 1,369
An Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 2×
“In this fed state, serum endocannabinoid levels are increased (Engeli et al., 2005; Matias et al., 2006).”
Matias, I., Gonthier, M.-P., Orlando, P., Martiadis, V., De Petrocellis, L., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2679 · Cited by 656
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Schaller, M. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.045112 · Cited by 599
Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J. P., Le Fur, G., Oury-Donat, F., & Soubrié, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.908 · Cited by 593
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
You, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202411200 · Cited by 543
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 527
Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D. N., Mendizabal-Zubiaga, J., Grandes, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.037 · Cited by 514
Pharmacology of Cannabinoid Receptors
Howlett, A. C. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 488
Self-citationAntifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Osei-Hyiaman, D., Liu, J., Zhou, L., Godlewski, G., Harvey-White, J., Jeong, W.-I., Bátkai, S., Marsicano, G., Lutz, B., Buettner, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34827 · Cited by 458
Tam, J., Vemuri, V. K., Liu, J., Bátkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S. V., Pickel, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42551 · Cited by 454
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_2 · Cited by 446
Self-citationInhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · Cancer Research · Cited by 422
The neurobiology and evolution of cannabinoid signalling
Elphick, M. R., & Egertova, M. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 417
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R., & Ozaita, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2369 · Cited by 385
Morrow, V. A., Foufelle, F., Connell, J. M. C., Petrie, J. R., Gould, G. W., & Salt, I. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212831200 · Cited by 359
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 359
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms13958 · Cited by 349
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing
Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Fur, G. L., Caput, D., & Ferrara, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3726 · Cited by 330
TNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents
Valerio, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28570 · Cited by 327
Signal transduction of the CB1 cannabinoid receptor
Turu, G., & Hunyady, L. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0190 · Cited by 325
Jeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308
Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Nitric oxide and mitochondrial biogenesis
Nisoli, E., & Carruba, M. O. (2006) · Journal of Cell Science · doi:10.1242/jcs.03062 · Cited by 279
Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Vogt, L. J., & Sim‐Selley, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732447.x · Cited by 273
McPartland, J. M., Glass, M., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707399 · Cited by 266
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
Onaivi, E. S., Ishiguro, H., Gong, J.-P., Patel, S., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001640 · Cited by 257
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 257
Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256
Effects of Cannabinoids on Neurotransmission
Szabo, B., & Schlicker, E. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_11 · Cited by 252
Zhang, P.-W., Ishiguro, H., Ohtsuki, T., Hess, J., Carillo, F., Walther, D., Onaivi, E. S., Arinami, T., & Uhl, G. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001560 · Cited by 247
Liu, Q. ‐., Pan, C. ‐., Hishimoto, A., Li, C. ‐., Xi, Z. ‐., Llorente‐Berzal, A., Viveros, M. ‐., Ishiguro, H., Arinami, T., Onaivi, E. S., et al. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00498.x · Cited by 246
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
Ujike, H., Takaki, M., Nakata, K., Tanaka, Y., Takeda, T., Kodama, M., Fujiwara, Y., Sakai, A., & Kuroda, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001029 · Cited by 228
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 219
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessègue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208
Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Griffin, G., Tao, Q., & Abood, M. E. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 207
Self-citationSong, Z. H., & Bonner, T. I. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09082-0 · Cited by 206
D’Souza, D. C., Cortes-Briones, J. A., Ranganathan, M., Thurnauer, H., Creatura, G., Surti, T., Planeta, B., Neumeister, A., Pittman, B., Normandin, M. D., et al. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.008 · Cited by 204
Endocannabinoids in liver disease
Tam, J., Liu, J., Mukhopadhyay, B., Cinar, R., Godlewski, G., & Kunos, G. (2011) · Hepatology · doi:10.1002/hep.24077 · Cited by 194
Cloning and molecular characterization of the rat CB2 cannabinoid receptor
Brown, S. M., Wager-Miller, J., & Mackie, K. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00341-x · Cited by 190
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Bosier, B., Muccioli, G. G., Hermans, E., & Lambert, D. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.013 · Cited by 188
Brain Cannabinoid CB2 Receptor in Schizophrenia
Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 184
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
Onaivi, E. S., Ishiguro, H., Gong, J., Patel, S., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.036 · Cited by 178
Cannabinoid receptor gene (CNR1): association with IV drug use
Comings, D. E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G., & MacMurray, J. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000247 · Cited by 175
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Liu, J., Zhou, L., Xiong, K., Godlewski, G., Mukhopadhyay, B., Tam, J., Yin, S., Gao, P., Shan, X., Pickel, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.032 · Cited by 173
APC mutations are sufficient for the growth of early colorectal adenomas
Lamlum, H., Papadopoulou, A., Ilyas, M., Rowan, A., Gillet, C., Hanby, A., Talbot, I., Bodmer, W., & Tomlinson, I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040564697 · Cited by 173
Fernández‐Ruíz, J., Moro, M. Á., & Martínez-Orgado, J. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0381-7 · Cited by 172
The evolution and comparative neurobiology of endocannabinoid signalling
Elphick, M. R. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0394 · Cited by 171
Navarro, G., Morales, P., Rodríguez‐Cueto, C., Fernández‐Ruíz, J., Jagerovic, N., & Franco, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00406 · Cited by 168
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., Dupré, D. J., & Denovan‐Wright, E. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557025 · Cited by 166
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 166
Cannabinoid receptors: nomenclature and pharmacological principles
Console-Bram, L., Marcu, J., & Abood, M. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.009 · Cited by 162
Self-citationTedesco, L., Valerio, A., Dossena, M., Cardile, A., Ragni, M., Pagano, C., Pagotto, U., Carruba, M. O., Vettor, R., & Nisoli, E. (2010) · Diabetes · doi:10.2337/db09-1881 · Cited by 162
Jourdan, T., Djaouti, L., Demizieux, L., Gresti, J., Vergès, B., & Degrace, P. (2010) · Diabetes · doi:10.2337/db09-1482 · Cited by 161
Atwood, B. K., Wager‐Miller, J., Haskins, C. P., Straiker, A. J., & Mackie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074013 · Cited by 160
CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids
McAllister, S. D., & Glass, M. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0344 · Cited by 159
Identification and characterisation of a novel splice variant of the human CB1 receptor
Ryberg, E., Vu, H. K., Larsson, N., Groblewski, T., Hjorth, S., Elebring, T., Sjögren, S., & Greasley, P. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.085 · Cited by 154
Griffin, G., Wray, E. J., Tao, Q., McAllister, S. D., Rorrer, W. K., Aung, M. M., Martin, B. R., & Abood, M. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00402-1 · Cited by 154
Self-citationAminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics
Eissenstat, M. A., Bell, M. R., D'Ambra, T. E., Alexander, E. J., Daum, S. J., Ackerman, J. H., Gruett, M. D., Kumar, V., & Estep, K. G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a013 · Cited by 153
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 151
Romero, J., García‐Palomero, E., Castro, J. G., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00277-x · Cited by 150
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Khajehali, E., Malone, D. T., Glass, M., Sexton, P. M., Christopoulos, A., & Leach, K. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099192 · Cited by 147
Tedesco, L., Valerio, A., Cervino, C., Cardile, A., Pagano, C., Vettor, R., Pasquali, R., Carruba, M. O., Marsicano, G., Lutz, B., et al. (2008) · Diabetes · doi:10.2337/db07-1623 · Cited by 145
Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein
Chakrabarti, A., Onaivi, E. S., & Chaudhuri, G. (1995) · DNA sequence · doi:10.3109/10425179509020870 · Cited by 140
Sipe, J. C., Arbour, N., Gerber, A., & Beutler, E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205111 · Cited by 139
Jordan, J. D., He, J. C., Eungdamrong, N. J., Gomes, I., Ali, W., Nguyen, T., Bivona, T. G., Philips, M. R., Devi, L. A., & Iyengar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411521200 · Cited by 132
He, C., Gomes, I., Nguyen, T., Jayaram, G., Ram, P. T., Devi, L. A., & Iyengar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502812200 · Cited by 129
Kearn, C. S., Greenberg, M. J., DiCamelli, R. F., Kurzawa, K., & Hillard, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722379.x · Cited by 122
Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse
da Cruz, J. F. O., Robin, L. M., Drago, F., Marsicano, G., & Metna‐Laurent, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.002 · Cited by 121
Barrero, F. J., Ampuero, I., Morales, B., Vives, F., Luna, J. D. D., Hoenicka, J., & de Yébenes, J. G. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500301 · Cited by 117
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarré, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 115
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor
Delgado‐Peraza, F., Ahn, K. H., Nogueras‐Ortiz, C. J., Mungrue, I. N., Mackie, K., Kendall, D. A., & Yudowski, G. A. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103176 · Cited by 115
Nguyen, P., Schmid, C. L., Raehal, K. M., Selley, D. E., Bohn, L., & Sim‐Selley, L. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.027 · Cited by 113
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Baillie, G. L., Horswill, J. G., Anavi‐Goffer, S., Reggio, P. H., Bolognini, D., Abood, M. E., McAllister, S. D., Strange, P. G., Stephens, G. J., Pertwee, R. G., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080879 · Cited by 113
Self-citationZhuang, S.-Y., Kittler, J. T., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R., & Deadwyler, S. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00232-0 · Cited by 110
Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528
Bouaboula, M., Dussossoy, D., & Casellas, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20397 · Cited by 107
Mukhopadhyay, B., Liu, J., Osei‐Hyiaman, D., Godlewski, G., Mukhopadhyay, P., Wang, L., Jeong, W., Gao, B., Duester, G., Mackie, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068460 · Cited by 107
3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor
Xie, X., Chen, J., & Billings, E. M. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10511 · Cited by 106
Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development
Díaz-Alonso, J., Guzmán, M., & Galve‐Roperh, I. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 105
Isolation and expression of a mouse CB1 cannabinoid receptor gene
Abood, M. E., Ditto, K. E., Noel, M. A., Showalter, V. M., & Tao, Q. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00727-7 · Cited by 102
Self-citationEllert‐Miklaszewska, A., Grajkowska, W., Gabrusiewicz, K. R., Kaminska, B., & Konarska, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.060 · Cited by 102
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101980 · Cited by 100
González‐Mariscal, I., Krzysik-Walker, S. M., Doyle, M. E., Liu, Q., Cimbro, R., Calvo, S. S.-C., Ghosh, S., Ciesla, L. M., Moaddel, R., Carlson, O. D., et al. (2016) · Scientific Reports · doi:10.1038/srep33302 · Cited by 98
Behavioral, Pharmacological, and Molecular Characterization of an Amphibian Cannabinoid Receptor
Soderstrom, K., Leid, M. E., Moore, F. L., & Murray, T. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750413.x · Cited by 95
A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene
Gadzicki, D., Müller‐Vahl, K., & Stuhrmann, M. (1999) · Molecular and Cellular Probes · doi:10.1006/mcpr.1999.0249 · Cited by 94
Cannabinoid receptor type-1: breaking the dogmas
Busquets-García, A., Gómez, E. S., Bellocchio, L., & Marsicano, G. (2016) · F1000Research · doi:10.12688/f1000research.8245.1 · Cited by 90
Yamada, Y., Ando, F., & Shimokata, H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.791 · Cited by 89
McKinney, D. L., Cassidy, M. P., Collier, L., Martin, B. R., Wiley, J. L., Selley, D. E., & Sim‐Selley, L. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130328 · Cited by 89
Grimsey, N. L., Goodfellow, C. E., Dragunow, M., & Glass, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.05.010 · Cited by 88
Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway
Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88
Cannabinoids and the human uterus during pregnancy
Dennedy, M. C., Friel, A. M., Houlihan, D. D., Broderick, V., Smith, T., & Morrison, J. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.07.013 · Cited by 86
Abood, M. E., Sauss, C., Fan, F., Tilton, C. L., & Martin, B. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90546-6 · Cited by 85
Self-citationEndocannabinoid receptor CB2 in nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Zamora‐Valdés, D., Pichardo-Bahena, R., Barredo-Prieto, B. A., Ponciano‐Rodríguez, G., Bermejo-Martínez, L., Chávez-Tapia, N. C., González, H. A. B., & Uribe, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01401.x · Cited by 83
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis
Benyamina, A., Kébir, O., Blecha, L., Reynaud, M., & Krebs, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00198.x · Cited by 79
He, C., Neves, S. R., Jordan, J. D., & Iyengar, R. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-025 · Cited by 79
Phylogenomic and chemotaxonomic analysis of the endocannabinoid system
McPartland, J. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.005 · Cited by 75
Lazáry, J., Lazáry, Á., Gonda, X., Benkő, A., Molnár, E., Hunyady, L., Juhász, G., & Bagdy, G. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31024 · Cited by 75
Cannabinoid receptor ligand bias: implications in the central nervous system
Laprairie, R. B., Bagher, A. M., & Denovan‐Wright, E. M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.10.005 · Cited by 74
Elphick, M. R., Satou, Y., & Satoh, N. (2003) · Gene · doi:10.1016/s0378-1119(02)01094-6 · Cited by 70
Regulation of neurite outgrowth by Gi/o signaling pathways
Kenneth, D. B. (2008) · Frontiers in bioscience · doi:10.2741/3022 · Cited by 68
Ishiguro, H., Carpio, O., Horiuchi, Y., Shu, A., Higuchi, S., Schanz, N., Benno, R. H., Arinami, T., & Onaivi, E. S. (2009) · Synapse · doi:10.1002/syn.20714 · Cited by 68
Chanda, D., Kim, D., Li, T., Kim, Y., Koo, S., Lee, C., Chiang, J. Y. L., & Choi, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224352 · Cited by 65
Ruby, M. A., Nomura, D. K., Hudak, C. S. S., Mangravite, L. M., Chiu, S., Casida, J. E., & Krauss, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807232105 · Cited by 65
Wu, H., Yang, Y. M., & Kim, S. G. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072769 · Cited by 65
The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940
Xie, X., Melvin, L. S., & Makriyannis, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10640 · Cited by 64
Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus
Karanian, D. A., Brown, Q. B., Makriyannis, A., & Bahr, B. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.009 · Cited by 62
Minocci, D., Massei, J., Martino, A., Milianti, M., Piz, L., Bello, D. D., Sbrana, A., Martinotti, E., Rossi, A. M., & Nieri, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.023 · Cited by 61
Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates
McPartland, J. M., & Glass, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00638-3 · Cited by 60
Cannabinoid receptor signaling regulates liver development and metabolism
Liu, L. Y., Alexa, K., Cortes, M., Schatzman-Bone, S., Kim, A. J., Mukhopadhyay, B., Çınar, R., Kunos, G., North, T. E., & Goessling, W. (2016) · Development · doi:10.1242/dev.121731 · Cited by 59
Martin, B. R., Dewey, W. L., Harris, L. S., et al. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30393-9 · Cited by 58
Zorina, Y., Iyengar, R., & Bromberg, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049841 · Cited by 58
Valk, P. J. M., Hol, S., Vankan, Y., Ihle, J. N., Askew, D. S., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Both, N. J. D., Löwenberg, B., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6796-6804.1997 · Cited by 58
DeMorrow, S., Francis, H., Gaudio, E., Ueno, Y., Venter, J. K., Onori, P., Franchitto, A., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2007 · Cited by 57
Molecular Biology of Cannabinoid Receptors
Abood, M. E. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_3 · Cited by 56
Self-citationDual Role of Fyn in the Regulation of FAK+6,7 by Cannabinoids in Hippocampus
Derkinderen, P., Toutant, M., Kadaré, G., Girault, J., Ledent, C. A., & Parmentier, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105630200 · Cited by 56
Flamment, M., Guéguen, N., Wetterwald, C., Simard, G., Malthièry, Y., & Ducluzeau, P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00169.2009 · Cited by 54
A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio)
McPartland, J. M., Glass, M., Matias, I., Norris, R. W., & Kilpatrick, C. W. (2007) · Molecular Genetics and Genomics · doi:10.1007/s00438-007-0207-3 · Cited by 52
Pai, W.-Y., Hsu, C.-C., Lai, C., Chang, T.-Z., Tsai, Y., & Her, G. M. (2013) · Transgenic Research · doi:10.1007/s11248-012-9685-0 · Cited by 46
Straiker, A. J., Wager‐Miller, J., Hutchens, J. M., & Mackie, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01744.x · Cited by 43
Karsak, M., Malkin, I., Toliat, M. R., Kubisch, C., Nürnberg, P., Zimmer, A., & Livshits, G. (2009) · Human Genetics · doi:10.1007/s00439-009-0708-8 · Cited by 42
Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese
Huang, Q., Li, G. H., & Kung, A. W. (2009) · Bone · doi:10.1016/j.bone.2009.01.368 · Cited by 39
Bagher, A. M., Laprairie, R. B., Kelly, M. E. M., & Denovan‐Wright, E. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.002 · Cited by 38
Brighton, P. J., McDonald, J. L., Taylor, A. H., Challiss, R. A. J., Lambert, D. G., Konje, J. C., & Willets, J. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0097 · Cited by 35
Δ9-Tetrahydrocannabinol activates [Ca2+]i increases partly sensitive to capacitative store refilling
Filipeanu, C. M., de Zeeuw, D., & Nelemans, S. A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01254-5 · Cited by 35
Dalton, G. D., Peterson, L. J., & Howlett, A. C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.03.020 · Cited by 34
Self-citationCottone, E., Salio, C., Conrath, M., & Franzoni, M. F. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10808 · Cited by 34
Bosier, B., Muccioli, G. G., Mertens, B., Sarre, S., Michotte, Y. M., Lambert, D. M., & Hermans, E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.003 · Cited by 31
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
Ndong, C., O’Donnell, D., Ahmad, S., & Groblewski, T. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.002 · Cited by 30
Kapur, A., Samaniego, P., Thakur, G. A., Makriyannis, A., & Abood, M. E. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133256 · Cited by 30
Self-citationElphick, M. R. (2002) · Biological Bulletin · doi:10.2307/1543648 · Cited by 29
Bosier, B., Tilleux, S., Najimi, M., Lambert, D. M., & Hermans, E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04679.x · Cited by 28
Brighton, P. J., Marczylo, T. H., Rana, S., Konje, J. C., & Willets, J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01425.x · Cited by 22
Reciprocal influences of CB1cannabinoid receptor agonists on ERK and JNK signalling in N1E‐115 cells
Bosier, B., Lambert, D. M., & Hermans, E. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.022 · Cited by 21
Ho, B. Y., & Zhao, J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12792-0 · Cited by 20
Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line
Begg, M., Baydoun, A. R., Parsons, M. E., & Molleman, A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0095j.x · Cited by 18
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level
Feng, Q., Vickers, K. C., Anderson, M. P., Levin, M. G., Chen, W., Harrison, D. G., & Wilke, R. A. (2013) · Nature Communications · doi:10.1038/ncomms2973 · Cited by 16
Endothelin‐1 inhibits TNFα‐induced iNOS expression in 3T3‐F442A adipocytes
Merial‐Kieny, C., Lonchampt, M., Cogé, F., Verwaerde, P., Galizzi, J., Boutin, J. A., Lafontan, M., Levens, N. R., Galitzky, J., & Félétou, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705325 · Cited by 16
Demuth, D. G., Gkoumassi, E., Dröge, M. J., Dekkers, B. G. J., Esselink, H. J., van Ree, R. M., Parsons, M. E., Zaagsma, J., Molleman, A., & Nelemans, S. A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20390 · Cited by 15
Ruiz‐Contreras, A. E., Román-López, T. V., Caballero-Sánchez, U., Rosas-Escobar, C. B., Ortega-Mora, E. I., Barrera-Tlapa, M. A., Romero‐Hidalgo, S., Carrillo‐Sánchez, K., Hernández-Morales, S., Vadillo‐Ortega, F., et al. (2016) · Memory · doi:10.1080/09658211.2016.1172642 · Cited by 12
Cited by
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Self-citationRole of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Fairhurst, C., Kumar, R., Checketts, D., Tayo, B., & Turner, S. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14548 · Cited by 53
Metadata
- Authors
- Howlett, A. C., & Abood, M. E.
- Venue
- Advances in Pharmacology
- Publisher
- Elsevier
- Published
- 2017
- Volume
- 80
- Pages
- 169-206
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W2626033047
- Cited by
- 375
- References
- 177
- FWCI
- 49.53
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.